AMX vs META
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMX exhibits mixed financial health with a Piotroski F-Score of 4/9 indicating borderline stability, while the absence of an Altman Z-Score prevents a full distress risk assessment. The stock appears reasonably valued with a current price of $20.76 below the growth-based intrinsic value of $37.76, though significantly above the conservative Graham Number of $3.26. Strong operating margins and ROE outperform sector averages, but weak earnings consistency, high debt/equity, and deteriorating short-term technical trend temper optimism. Analysts recommend a 'buy' with a $23.40 target, implying moderate upside.
META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.
Compare Another Pair
Related Comparisons
AMX vs META: Head-to-Head Comparison
This page compares América Móvil, S.A.B. de C.V. (AMX) and Meta Platforms, Inc. (META) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.